Treatment coverage for schistosomiasis by country
Drug coverage out of estimated population who require it.
Countries reporting
45
Highest
100.0%
Rwanda
Lowest
0.2%
Brazil
Median
46.8%
Years covered
19
2006–2024
Data points
573
What the numbers show
Treatment coverage for schistosomiasis is currently reported for 45 countries. The highest value is 100.0% in Rwanda; the lowest is 0.2% in Brazil.
The median across all reporting countries is 46.8%, and the mean is 49.6%.
The gap between the highest and lowest reporting country is a factor of about 588.
Over the past decade 31 countries rose and 14 fell. The largest increase was in Indonesia (up 40,367.6%), and the largest decrease in Mozambique (down 96.4%).
Treatment coverage for schistosomiasis: full country ranking
| # | Country | Latest | Year | 10-year change | Trend |
|---|---|---|---|---|---|
| 1 | Rwanda | 100.0% | 2024 | up 1,215.8% | volatile |
| 2 | Egypt | 98.8% | 2020 | down 1.2% | volatile |
| 3 | China | 98.1% | 2015 | up 360.7% | volatile |
| 4 | Burkina Faso | 89.0% | 2024 | up 42.7% | rising |
| 5 | Zambia | 87.2% | 2023 | up 340.3% | volatile |
| 6 | Togo | 86.0% | 2024 | up 59.2% | falling |
| 7 | Kenya | 84.6% | 2024 | up 259.9% | volatile |
| 8 | Laos | 82.9% | 2024 | up 11.5% | rising |
| 9 | Yemen | 78.7% | 2022 | up 266.0% | volatile |
| 10 | Cambodia | 76.0% | 2024 | up 117.8% | falling |
| 11 | Sierra Leone | 73.2% | 2024 | down 21.4% | falling |
| 12 | Somalia | 68.5% | 2023 | up 3,317.8% | volatile |
| 13 | Benin | 66.2% | 2024 | up 40.2% | volatile |
| 14 | Philippines | 64.9% | 2024 | up 338.6% | volatile |
| 15 | Cameroon | 56.3% | 2024 | down 0.8% | volatile |
| 16 | Uganda | 54.3% | 2024 | up 108.9% | volatile |
| 17 | Zimbabwe | 53.7% | 2024 | up 9.8% | flat |
| 18 | Eswatini | 53.5% | 2024 | up 3.6% | volatile |
| 19 | Nigeria | 49.6% | 2024 | up 351.2% | volatile |
| 20 | Angola | 48.4% | 2024 | up 236.0% | volatile |
| 21 | Guinea | 48.0% | 2024 | up 42.9% | rising |
| 22 | Liberia | 47.4% | 2024 | up 63.5% | volatile |
| 23 | Ethiopia | 46.8% | 2024 | up 516.4% | rising |
| 24 | Sao Tome and Principe | 42.8% | 2021 | down 40.5% | falling |
| 25 | Eritrea | 42.8% | 2023 | up 141.5% | volatile |
| 26 | Madagascar | 41.4% | 2024 | up 56.1% | volatile |
| 27 | Indonesia | 40.5% | 2024 | up 40,367.6% | volatile |
| 28 | Malawi | 40.1% | 2024 | down 29.5% | volatile |
| 29 | Senegal | 39.7% | 2024 | down 22.4% | volatile |
| 30 | Mali | 39.3% | 2024 | up 326.8% | volatile |
| 31 | Democratic Republic of Congo | 38.5% | 2024 | up 223.1% | rising |
| 32 | Chad | 38.0% | 2024 | down 34.2% | falling |
| 33 | Congo | 37.0% | 2023 | up 1,749.5% | volatile |
| 34 | Ghana | 36.6% | 2024 | up 85.6% | volatile |
| 35 | Tanzania | 35.7% | 2024 | up 30.6% | rising |
| 36 | Niger | 35.1% | 2024 | down 62.0% | volatile |
| 37 | Sudan | 35.1% | 2022 | up 3,253.8% | volatile |
| 38 | Cote d'Ivoire | 27.2% | 2024 | down 24.6% | volatile |
| 39 | Central African Republic | 13.9% | 2024 | up 48.1% | volatile |
| 40 | Mauritania | 12.6% | 2024 | up 31.0% | volatile |
| 41 | South Sudan | 10.7% | 2023 | down 33.3% | volatile |
| 42 | Guinea-Bissau | 8.5% | 2024 | down 78.0% | volatile |
| 43 | Burundi | 4.3% | 2024 | down 90.6% | rising |
| 44 | Mozambique | 1.0% | 2023 | down 96.4% | volatile |
| 45 | Brazil | 0.2% | 2022 | down 90.7% | volatile |
About this data
Drug coverage out of estimated population who require it.